Electric Smoke Vapor House manufactured and distributed e-liquid products containing nicotine without obtaining required premarket authorization from the FDA, violating the Family Smoking Prevention and Tobacco Control Act. The company's products were determined to be tobacco products subject to FDA jurisdiction under the Federal Food, Drug, and Cosmetic Act, particularly following the March 2022 legislation that extended FDA oversight to all nicotine-containing products regardless of the nicotine source. The warning was issued after FDA review of the company's submissions and inspection records revealed the products were being manufactured and offered for sale without compliance with mandatory premarket approval requirements for new tobacco products.